November 30, 2020

Cedilla and HitGen Announce Research Collaboration Focused on DNA-Encoded Library Based Drug Discovery

October 13, 2020

Cedilla Therapeutics Announces $57.6 Million Series B Financing

October 23, 2019

Cedilla Therapeutics Appoints Justin Birtz as Vice President, People and Culture

May 14, 2019

Cedilla Therapeutics Appoints Delphine Collin, Ph.D., as Vice President, Biomolecular Sciences

July 10, 2018

Cedilla Therapeutics Appoints Rosana Kapeller to Board of Directors

June 28, 2018

Cedilla Therapeutics Expands Leadership Team with New Appointments to Direct Biology, Drug Discovery and Proteomics

April 24, 2018

Third Rock Ventures Launches Cedilla Therapeutics with $56 Million Investment to Target Protein Stability Using Small Molecule Therapeutics